Term
|
Definition
secretion of estrogen, progesterone, gonadotropin, inhibin, placental lactogen and other
hormones |
|
|
Term
|
Definition
| increased secretion of prolactin and ACTH, secretes very little FSH and LH |
|
|
Term
|
Definition
| increased secretion of aldosterone and cortisol |
|
|
Term
|
Definition
| increased secretion of vasopressin |
|
|
Term
|
Definition
| increased secretion of parathyroid hormone to increase Ca in the blood. Binds to osteoblasts to form new osteoclasts which ultimately enhances the resorption of bone. In kidney, enhances active reabsorption of calcium from distal tubules and the thick ascending limb. Also enhances the absorption of calcium in the intestine by increasing the production of activated vitamin D. |
|
|
Term
|
Definition
| increased secretion of renin, erythropoietin, and 1,25 dihydroxyvitam D3 |
|
|
Term
|
Definition
enlarge and develop mature grandular structure. cause: Estrogen, progesterone,
prolactin, and placental lactogen |
|
|
Term
|
Definition
increases cause: total erythrocyte volume is increased by erythropoietin and
plasma volume by salt and water retention |
|
|
Term
|
Definition
| Positive. Cause: increased parathyroid hormone and 1,25 dihydroxyvitamin D3 |
|
|
Term
|
Definition
| increases by an average of 12.5 kg, 60 percent of which is water |
|
|
Term
|
Definition
Cardiac output increases, total peripheral resistance decreases (vasodilation in
uterus, skin, breasts, GI tract, and kidneys), mean arterial pressure stays constant |
|
|
Term
|
Definition
| hyperventilation (arterial PCO2 decreases) |
|
|
Term
|
Definition
Metabolic rate increases. Plasma glucose, gluconeogenesis, fatty acid
mobilization all increase. Cause: hyporesponsiveness to insulin due to insulin antagonism by
placental lactogen and cortisol. |
|
|
